AVANIR Pharmaceuticals (NASDAQ:AVNR)

CAPS Rating: 1 out of 5

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

Recs

0
Player Avatar efarev (98.98) Submitted: 7/24/2010 4:49:46 AM : Outperform Start Price: $3.34 AVNR Score: +44.35

upcoming FDA decision

Featured Broker Partners


Advertisement